{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:54:33Z","timestamp":1793073273432,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81670293"],"award-info":[{"award-number":["81670293"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinical Research Program of 9th People's"},{"DOI":"10.13039\/100008235","name":"School of Medicine","doi-asserted-by":"publisher","award":["JYLJ201803"],"award-info":[{"award-number":["JYLJ201803"]}],"id":[{"id":"10.13039\/100008235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008235","name":"School of Medicine","doi-asserted-by":"publisher","award":["16CR2034B"],"award-info":[{"award-number":["16CR2034B"]}],"id":[{"id":"10.13039\/100008235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008235","name":"School of Medicine","doi-asserted-by":"publisher","award":["YBKA201910"],"award-info":[{"award-number":["YBKA201910"]}],"id":[{"id":"10.13039\/100008235","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Science and Technology Commission","award":["18411950500"],"award-info":[{"award-number":["18411950500"]}]},{"DOI":"10.13039\/501100014137","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014137","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ijcard.2020.08.065","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T11:36:06Z","timestamp":1598441766000},"page":"148-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Characteristics, prognosis and treatment response in distinct phenogroups of heart failure with preserved ejection fraction"],"prefix":"10.1016","volume":"323","author":[{"given":"Jun","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-an","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2020.08.065_bb0005","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.08.065_bb0010","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/eurheartj\/ehq426","article-title":"Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment","volume":"32","author":"Borlaug","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.08.065_bb0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nrcardio.2012.123","article-title":"The many faces of heart failure with preserved ejection fraction","volume":"9","author":"Shah","year":"2012","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcard.2020.08.065_bb0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12265-017-9756-y","article-title":"Precision medicine for heart failure with preserved ejection fraction: an overview","volume":"10","author":"Shah","year":"2017","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.ijcard.2020.08.065_bb0025","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/ejhf.327","article-title":"McMurray JJ2, Lindenfeld J. characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response","volume":"17","author":"Kao","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.08.065_bb0030","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/heartjnl-2019-315481","article-title":"Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning","volume":"106","author":"Hedman","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2020.08.065_bb0035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.08.065_bb0040","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jchf.2019.09.009","article-title":"Clinical phenogroups in heart failure with preserved ejection fraction: detailed phenotypes, prognosis, and response to spironolactone","volume":"8","author":"Cohen","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ijcard.2020.08.065_bb0045","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ejhf.1621","article-title":"Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis","volume":"22","author":"Segar","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ijcard.2020.08.065_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/ehf2.12619","article-title":"Characteristics and outcomes of transitions among heart failure categories: a prospective observational cohort study","author":"Gu","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.ijcard.2020.08.065_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/HYPERTENSIONAHA.119.14057","article-title":"Medical therapies for heart failure with preserved ejection fraction","volume":"75","author":"Kjeldsen","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2020.08.065_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.echo.2019.06.017","article-title":"Myocardial strain for identification of \u03b2-blocker responders in heart failure with preserved ejection fraction","volume":"32","author":"Park","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ijcard.2020.08.065_bb0065","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/HJH.0000000000001932","article-title":"Different prognostic associations of beta-blockers and diuretics in heart failure with preserved ejection fraction with versus without high blood pressure","volume":"37","author":"Matsushita","year":"2019","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ijcard.2020.08.065_bb0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijcard.2016.11.239","article-title":"The effect of beta-blockers on mortality in heart failure with preserved ejection fraction: a meta analysis of observational cohort and randomized controlled studies","volume":"228","author":"Fukuta","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.08.065_bb0075","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.2014.15241","article-title":"Association between use of beta-blockers and outcomes in patients with heart failure and preserved ejection fraction","volume":"312","author":"Lund","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2020.08.065_bb0080","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.jacc.2009.02.046","article-title":"Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure)","volume":"53","author":"van Veldhuisen","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.08.065_bb0085","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/eurjhf\/hfs141","article-title":"Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF)","volume":"15","author":"Yamamoto","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.08.065_bb0090","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10557-018-6818-6","article-title":"The use of oral beta-blockers and clinical outcomes in patients with non-ST-segment elevation acute coronary syndromes: a long-term follow-up study","volume":"32","author":"Nicolau","year":"2018","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ijcard.2020.08.065_bb0095","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/heartjnl-2017-311652","article-title":"Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"104","author":"Zheng","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2020.08.065_bb0100","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2337\/dc09-2227","article-title":"Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. general practice research database","volume":"33","author":"MacDonald","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2020.08.065_bb0105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12933-018-0739-3","article-title":"Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus","volume":"17","author":"Gu","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ijcard.2020.08.065_bb0110","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2020.08.065_bb0115","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.08.065_bb0120","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.08.065_bb0125","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jacc.2005.11.073","article-title":"Angiotensin converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function. A systematic review and meta-analysis of randomized controlled trials","volume":"47","author":"Al-Mallah","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.08.065_bb0130","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cardfail.2005.09.001","article-title":"Angiotensin-converting enzyme inhibitors prescription is associated with longer survival among patients hospitalized for congestive heart failure who have preserved systolic function: a long-term follow-up study","volume":"12","author":"Grigorian Shamagian","year":"2006","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2020.08.065_bb0135","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijcard.2016.06.190","article-title":"Association between long-term prescription of aldosterone antagonist and the progression ofheart failure with preserved ejection fraction in hypertensive patients","volume":"220","author":"Gu","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.08.065_bb0140","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"PARAGON-HF Investigators and Committees. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320336482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320336482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:48:35Z","timestamp":1759092515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527320336482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":28,"alternative-id":["S0167527320336482"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.08.065","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics, prognosis and treatment response in distinct phenogroups of heart failure with preserved ejection fraction","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.08.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}